Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 103

The DOI matches its Crossref record.

Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (cgp 69846a) after intravenous and subcutaneous administration

Phillips, J.A, Craig, S.J, Bayley, D, Christian, R.A, Geary, R, Nicklin, P.L · 1997 · Biochemical Pharmacology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0006-2952(97)00190-1

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 24

  1. Helene, 1990, Specific regulation of gene expression by antisense, sense and antigene nucleic acids, Biochim Biophys Acta, 1049, 99, 10.1016/0167-4781(90)90031-V · DOI · Paper page
  2. Monia, 1996, Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against c-raf kinase, Nat Med, 2, 668, 10.1038/nm0696-668 · DOI · Paper page
  3. Dean, 1996, Inhibition of human tumor cell lines in nude mice by an antisense inhibitor of PKC-α expression, Cancer Res, 56, 3499
  4. Agrawal, 1992, Antisense oligonucleotides as antiviral agents, Trends Biotechnol Sci, 10, 152, 10.1016/0167-7799(92)90203-8 · doi:10.1016/0167-7799(92)90203-8
  5. Goodarzi, 1992, Organ distribution and stability of phosphorothioated oligodeoxyribonucleotides in mice, Biopharmacol Drug Dispos, 13, 221, 10.1002/bdd.2510130308 · doi:10.1002/bdd.2510130308
  6. Iversen, 1991, In vivo studies with phosphorothioate oligonucleotides: Pharmacokinetics prologue, AntiCancer Drug Design, 6, 531
  7. Cossum, 1993, Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats, J Pharmacol Exp Ther, 267, 1181
  8. Sands, 1994, Biodistribution and metabolism of internally 3H-labeled oligonucleotides. 1. Comparison of a phosphodiester and a phosphorothioate, Mol Pharmacol, 45, 932
  9. Agrawal, 1995, Pharmacokinetics of antisense oligonucleotides, Clin Pharmacokinet, 28, 7, 10.2165/00003088-199528010-00002 · DOI · Paper page
  10. Zhang, 1995, Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM-91) developed as a therapeutic agent for human immunodeficiency virus type-1, Biochem Pharmacol, 49, 929, 10.1016/0006-2952(95)00010-W · DOI
  11. Crooke, 1996, Pharmacokinetic properties of several oligonucleotide analogs in mice, J Pharmacol Exp Ther, 277, 923
  12. Rifai, 1996, Clearance kinetics, biodistribution and organ saturability of phosphorothioate oligodeoxynucleotides iin mice, Am J Pathol, 149, 717
  13. Cossum, 1994, Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intradermal administration to rats, J Pharmacol Exp Ther, 269, 89
  14. Saijo, 1994, Pharmacokinetics, tissue distribution and stability of antisense oligodeoxynucleotide phosophorothioate ISIS 3466 in mice, Oncol Res, 6, 243
  15. Leeds, 1996, Quantification of phosphorothioate oligonucleotides in human plasma, Anal Biochem, 235, 36, 10.1006/abio.1996.0088 · DOI
  16. Graham, 1993, Tritium labeling of antisense oligonucleotides by exchange with tritiated water, Nucleic Acids Res, 21, 3737, 10.1093/nar/21.16.3737 · DOI
  17. Crooke, 1991, In vitro toxicology and pharmacokinetics of antisense oligonucleotides, Anticancer Drug Design, 6, 609
  18. Beck, 1996, Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial cells, Pharmacol Res, 13, 1028, 10.1023/A:1016002606705 · DOI
  19. Spitzer, 1988, Inhibition of deoxyribonucleases by phosphorothioate groups in oligodeoxyribonucleotides, Nucleic Acids Res, 16, 11691, 10.1093/nar/16.24.11691 · DOI
  20. Temsamani, 1993, Pharmacokinetics, biodistribution and stability of capped oligodeoxynucleotide phosphorothioates in mice, Antisense Res Dev, 3, 277, 10.1089/ard.1993.3.277 · DOI
  21. Tang, 1993, Self-stabilized anti-sense oligodeoxynucleotide phosphorothioates: Properties and anti-HIV activity, Nucleic Acids Res, 21, 2729, 10.1093/nar/21.11.2729 · DOI
  22. Zhang, 1995, In vivo stability and disposition of a self-stabilized oligodeoxynucleotide phosphorothioate in rats, Clin Chem, 41, 836, 10.1093/clinchem/41.6.836 · DOI
  23. Galbraith, 1994, Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey, Antisense Res Dev, 4, 201, 10.1089/ard.1994.4.201 · DOI · Paper page
  24. Cornish, 1993, Cardiovascular effects of a phosphorothioate oligonucleotide with a sequence antisense to p53 in the conscious rhesus monkey, Pharmacol Commun, 3, 239

Cited by

See all 103

Metadata

Authors
Phillips, J. A., Craig, S. J., Bayley, D., Christian, R. A., Geary, R., & Nicklin, P. L.
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
1997-09
Volume
54
Issue
6
Pages
657-668
ISSN
0006-2952
Cited by
103
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (cgp 69846a) after intravenous and subcutaneous administration. https://app.cochat.ai/papers/10.1016/s0006-2952(97)00190-1
The paper
Phillips, J. A., Craig, S. J., Bayley, D., Christian, R. A., Geary, R., & Nicklin, P. L. (1997). Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (cgp 69846a) after intravenous and subcutaneous administration. Biochemical Pharmacology. https://doi.org/10.1016/s0006-2952(97)00190-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.